Clinical Trial

Combination of Diet and Oral Budesonide for Ulcerative Colitis

Study acronym: ReDUCE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 23, 2024 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The ReDUCE Trial is a multinational single-blinded randomized controlled trial in mild to moderate flare of Ulcerative colitis (UC) disease patients. The purpose of the study is to validate the clinical efficacy of the UCED (Ulcerative colitis Exclusion Diet) with partial enteral nutrition (PEN) using a novel formula. The investigators anticipate that adding a novel specifically designed dietary intervention in addition to drug will lead to superior remission and mucosal healing via changes in the microbiome.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-16.
Status change: Not Yet Recruiting → Recruiting 2024-05-21
Trial Details
NCT Number NCT05791487
Lead Sponsor Wolfson Medical Center
Conditions Ulcerative Colitis, Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate
Enrollment 90 participants
Start Date 2023-12-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-05-23